The hypoxic microenvironment possibly allows tumor cells to compete with immune cells for glutamine (Xia et al., 2021), and the significant activation of glutamine metabolism in tumor cells and the upregulation of EPHB2 expression make LUAD invasive and immunosuppressive. Here, EPHB2 is linked to neoplasm.